AC Immune ACIU
NASDAQ ACIU
$2.60 -0.01 (-0.38%)
At close: Sep 29, 2026 · 4:00 PM EDT

AC Immune (ACIU) EV to EBITDA (2018 - 2019)

Updated

AC Immune's EV to EBITDA came in at 10.45 for the quarter ended Dec 31, 2019, compared with 0.56 a year earlier.

Analysis

AC Immune (ACIU) EV to EBITDA (2018 - 2019) Analysis & Trends

For the year ended Dec 31, 2019, AC Immune's EV to EBITDA was 6.98.

  • Going back by year, EV to EBITDA was 0.55 in the year ended Dec 31, 2018.
  • Business Quant data shows ACIU's EV to EBITDA at 0.03 (quarter ended Sep 30, 2019), 0.09 (quarter ended Jun 30, 2019) and 0.04 (quarter ended Mar 31, 2019) in the three quarters before the quarter ended Dec 31, 2019.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 AC Immune 265.55 Mn 265.55 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2019 10.45
Sep 30, 2019 0.03
Jun 30, 2019 0.09
Mar 31, 2019 0.04
Dec 31, 2018 0.56
API Access

AC Immune EV to EBITDA API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=ACIU&period=max&api_key=YOUR_API_KEY